Trial Profile
An Open-label, Randomized, Cross-over Study to Evaluate Pharmacokinetics and the Safety of HL068 16/10mg Compared to Candesartan 16mg and Amlodipine 10mg Co-administered in Healthy Male Volunteers.
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2018
Price :
$35
*
At a glance
- Drugs Amlodipine/candesartan-cilexetil (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors HanAll Biopharma
- 13 Dec 2016 New trial record